OBJECTIVE: The goals of the study were to estimate the pharmacokinetic parameters of standard dose betamethasone in a large obstetrics population and evaluate the effect of maternal body size and multiple gestation on the pharmacokinetic parameters and their observed variability. STUDY DESIGN: This was a prospective pharmacokinetic study. Liquid chromatography mass spectrometry was used to measure betamethasone plasma concentrations. Pharmacokinetic parameters and significant clinical covariates were estimated with mixed effect modeling. Bootstrap analysis confirmed validity of the model. RESULTS: Two hundred seventy-four blood samples from 77 patients were obtained. The greatest effect on pharmacokinetic variability was observed with maternal lean body weight (LBW). The relationship between the pharmacokinetic parameters and LBW remained linear over a wide range of maternal body sizes. Multiple gestations did not affect the pharmacokinetic parameters. CONCLUSION: Individualization of betamethasone dosing by maternal LBW reduces variability in drug exposure. Mutiple gestations do not require betamethasone dosing adjustment, because pharmacokinetics are the same as singleton gestations. Published by Mosby, Inc.
OBJECTIVE: The goals of the study were to estimate the pharmacokinetic parameters of standard dose betamethasone in a large obstetrics population and evaluate the effect of maternal body size and multiple gestation on the pharmacokinetic parameters and their observed variability. STUDY DESIGN: This was a prospective pharmacokinetic study. Liquid chromatography mass spectrometry was used to measure betamethasone plasma concentrations. Pharmacokinetic parameters and significant clinical covariates were estimated with mixed effect modeling. Bootstrap analysis confirmed validity of the model. RESULTS: Two hundred seventy-four blood samples from 77 patients were obtained. The greatest effect on pharmacokinetic variability was observed with maternal lean body weight (LBW). The relationship between the pharmacokinetic parameters and LBW remained linear over a wide range of maternal body sizes. Multiple gestations did not affect the pharmacokinetic parameters. CONCLUSION: Individualization of betamethasone dosing by maternal LBW reduces variability in drug exposure. Mutiple gestations do not require betamethasone dosing adjustment, because pharmacokinetics are the same as singleton gestations. Published by Mosby, Inc.
Authors: Praveen Ballabh; E S Lo; J Kumari; T B Cooper; I Zervoudakis; P A M Auld; A N Krauss Journal: Clin Pharmacol Ther Date: 2002-01 Impact factor: 6.875
Authors: Jacqueline B McCrea; Anup K Majumdar; Michael R Goldberg; Marian Iwamoto; Cynthia Gargano; Deborah L Panebianco; Michael Hesney; Christopher R Lines; Kevin J Petty; Paul J Deutsch; M Gail Murphy; Keith M Gottesdiener; D Ronald Goldwater; Robert A Blum Journal: Clin Pharmacol Ther Date: 2003-07 Impact factor: 6.875
Authors: Yi Luo; Cornelius E Uboh; Lawrence R Soma; Fuyu Guan; Jeffrey A Rudy; Deborah S Tsang Journal: Rapid Commun Mass Spectrom Date: 2005 Impact factor: 2.419
Authors: Alan H Jobe; Ilias Nitsos; J Jane Pillow; Graeme R Polglase; Suhas G Kallapur; John P Newnham Journal: Am J Obstet Gynecol Date: 2009-10-03 Impact factor: 8.661
Authors: Thomas K Wiersma; Marijn C Visschedijk; Nanne K de Boer; Marjolijn N Lub-de Hooge; Jelmer R Prins; Daan J Touw; Paola Mian Journal: Pharmaceutics Date: 2022-06-11 Impact factor: 6.525
Authors: James H Fischer; Gloria E Sarto; Jennifer Hardman; Loraine Endres; Thomas M Jenkins; Sarah J Kilpatrick; Hyunyoung Jeong; Stacie Geller; Kelly Deyo; Patricia A Fischer; Keith A Rodvold Journal: Clin Pharmacokinet Date: 2014-04 Impact factor: 6.447
Authors: Liina Süvari; Otto M Helve; M Anneli Kari; L Ursula Turpeinen; P Anniina Palojärvi; Markus J Leskinen; Sture Andersson; A Cecilia Janér Journal: Pediatr Res Date: 2020-07-14 Impact factor: 3.756
Authors: Augusto F Schmidt; Alan H Jobe; Paranthaman S Kannan; James P Bridges; John P Newnham; Masatoshi Saito; Haruo Usuda; Yusaku Kumagai; Erin L Fee; Michael Clarke; Matthew W Kemp Journal: Pediatr Res Date: 2019-07-31 Impact factor: 3.756